FDA inspection
Siegfried (Nantong) Pharmaceuticals Co., Ltd.: FDA inspection ending Aug 16, 2019
FDA inspection 1103042 · No Action Indicated (NAI) · Nantong
Key facts
| Inspection ID | 1103042 |
|---|---|
| Firm | Siegfried (Nantong) Pharmaceuticals Co., Ltd. |
| FEI number | 3013046521 |
| Address | Dev. Area, Economic & Technological |
| City | Nantong |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Aug 16, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data